These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 39419479)
1. Dissolution, phase behavior and mass transport of amorphous solid dispersions in aspirated human intestinal fluids. Elkhabaz A; Moseson DE; Brouwers J; Augustijns P; Taylor LS J Pharm Sci; 2025 Jan; 114(1):336-349. PubMed ID: 39419479 [TBL] [Abstract][Full Text] [Related]
2. Impact of dissolution medium pH and ionization state of the drug on the release performance of amorphous solid dispersions. Indulkar AS; Alex S; Zhang GGZ J Pharm Sci; 2025 Jan; 114(1):497-506. PubMed ID: 39454946 [TBL] [Abstract][Full Text] [Related]
3. Chemistry and ionization of HPMCAS influences the dissolution and solution-mediated crystallization of posaconazole amorphous solid dispersions. Shah DD; Taylor LS J Pharm Sci; 2025 Jan; 114(1):223-233. PubMed ID: 39243976 [TBL] [Abstract][Full Text] [Related]
4. Amorphous Solid Dispersion Formation for Enhanced Release Performance of Racemic and Enantiopure Praziquantel. Polyzois H; Nguyen HT; Roberto de Alvarenga Junior B; Taylor LS Mol Pharm; 2024 Oct; 21(10):5285-5296. PubMed ID: 39292641 [TBL] [Abstract][Full Text] [Related]
5. Exploring biorelevant conditions and release profiles of ritonavir from HPMCAS-based amorphous solid dispersions. Bapat P; Schwabe R; Paul S; Tseng YC; Bergman C; Taylor LS J Pharm Sci; 2025 Jan; 114(1):185-198. PubMed ID: 39186978 [TBL] [Abstract][Full Text] [Related]
6. Improving oral absorption of a rapidly crystallizing parent drug using prodrug strategy: Comparison of phosphate versus glycine based prodrugs. Indulkar AS; Slade R; Jana N; Frey RR; Penning TD; Lai A; Leblanc AF J Pharm Sci; 2025 Jan; 114(1):279-288. PubMed ID: 39368743 [TBL] [Abstract][Full Text] [Related]
7. Amorphous solid dispersions of amphiphilic polymer excipients and indomethacin prepared by hot melt extrusion. Keßler L; Mishra R; Hietala S; Lammens M; Peltonen L; Rades T; van Veen B; Juppo A; Laaksonen T; Strachan C; Luxenhofer R Eur J Pharm Sci; 2025 Jan; 204():106960. PubMed ID: 39522738 [TBL] [Abstract][Full Text] [Related]
8. Impact of surfactants on solution behavior and membrane transport of amorphous solid dispersions. Alhalaweh A; Sayed ME; Kovac L; Bergström CAS J Pharm Sci; 2025 Jan; 114(1):458-467. PubMed ID: 39491671 [TBL] [Abstract][Full Text] [Related]
9. Vehicle effect on in-vitro and in-vivo performance of spray-dried dispersions. Nespi M; Ly J; Fan Y; Chen S; Liu L; Gu Y; Castleberry S J Pharm Sci; 2025 Jan; 114(1):566-576. PubMed ID: 39486520 [TBL] [Abstract][Full Text] [Related]
10. Understanding the effect of plasticizers in film coat materials on the physical stability of amorphous solid dispersions. Chatterjee K; Punia A; Confer AM; Lamm MS J Pharm Sci; 2025 Jan; 114(1):468-476. PubMed ID: 39505068 [TBL] [Abstract][Full Text] [Related]
11. Impact of HPMCAS Grade on the Release of Weakly Basic Drugs from Amorphous Solid Dispersions. Bapat P; Taylor LS Mol Pharm; 2024 Dec; ():. PubMed ID: 39704640 [TBL] [Abstract][Full Text] [Related]
12. Prediction of Successful Amorphous Solid Dispersion Pairs through Liquid State Nuclear Magnetic Resonance. Coutinho AL; Hom K; Polli JE Mol Pharm; 2024 Dec; 21(12):6153-6165. PubMed ID: 39482969 [TBL] [Abstract][Full Text] [Related]
13. Urgent carotid endarterectomy with distal mechanical thrombectomy. Muhammad N; Ramayya A; Burkhardt JK; Srinivasan VM J Neurointerv Surg; 2024 Dec; ():. PubMed ID: 38906686 [TBL] [Abstract][Full Text] [Related]
14. Amorphous Solid Dispersions of Glycyrrhetinic Acid: Using Soluplus, PVP, and PVPVA as the Polymer Matrix to Enhance Solubility, Bioavailability, and Stability. Zhao MY; Shi XB; Chang JH; Wang RX; Zhou JY; Liu P AAPS PharmSciTech; 2024 Dec; 26(1):18. PubMed ID: 39707118 [TBL] [Abstract][Full Text] [Related]
15. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults. Love AMA; Edwards C; Cai RY; Gibbs V Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059 [TBL] [Abstract][Full Text] [Related]
16. Identifying Body Awareness-Related Brain Network Changes after Cognitive Multisensory Rehabilitation for Neuropathic Pain Relief in Adults with Spinal Cord Injury: Delayed Treatment arm Phase I Randomized Controlled Trial. Van de Winckel A; Carpentier ST; Deng W; Bottale S; Zhang L; Hendrickson T; Linnman C; Lim KO; Mueller BA; Philippus A; Monden KR; Wudlick R; Battaglino R; Morse LR medRxiv; 2023 Feb; ():. PubMed ID: 36798345 [TBL] [Abstract][Full Text] [Related]
17. High-Throughput Microarray Approaches for Predicting the Stability of Drug-Polymer Solid Dispersions. Ghazi NF; Burley JC; Dryden IL; Roberts CJ Mol Pharm; 2024 Dec; ():. PubMed ID: 39707995 [TBL] [Abstract][Full Text] [Related]
18. Interventions to increase patient and family involvement in escalation of care for acute life-threatening illness in community health and hospital settings. Mackintosh NJ; Davis RE; Easter A; Rayment-Jones H; Sevdalis N; Wilson S; Adams M; Sandall J Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012829. PubMed ID: 33285618 [TBL] [Abstract][Full Text] [Related]
19. Solution-mediated phase transformation of cocrystals at the solid-liquid interface: Relationships between the supersaturation generation rate and transformation pathway. Fan R; Chen A; Yu Y; Cai T; Guo M Int J Pharm; 2025 Jan; 668():124969. PubMed ID: 39566698 [TBL] [Abstract][Full Text] [Related]
20. Dynamic Phase Behavior of Amorphous Solid Dispersions Revealed with Tomberg T; Hämäläinen I; Strachan CJ; van Veen B Mol Pharm; 2024 Dec; 21(12):6444-6457. PubMed ID: 39561293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]